• Can changes in EEG improve neuropathic pain treatments - read Oct newsletter.
  • Nine posters ready to reveal at the SfN virtual conference 8-11 Nov, booth 1818.
  • Joined-up preclinical and clinical trials to advance psilocybin drug development
  • Transpharmation joins HaPpY team to help break the vicious cycle of chronic pain & mood disorders, see News for details
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • New state-of-the-art premises at Discovery Park, Kent


News you can use


All the latest conference updates; those that we are attending and the studies that we are presenting

Covid-19 update: April


During these unprecedented times, good communication and maintaining contact is more important than ever. That's why at Transpharmation we're making use of all the resources available for holding regular meetings with our clients to discuss ongoing and future projects. Although some of us are working from home and juggling family commitments, we remain close to you. We're all in this together and it's nice to stay in touch.

Contact me at any time: This email address is being protected from spambots. You need JavaScript enabled to view it.


Start a Conversation

preclinical +44 (0)203 633 2807

clinical trials +353 (0)1896 42 60

clinical research +48 515 244 120

EEG contact@transpharmation.co.uk

Copyright ©2021 Transpharmation Ltd. Website created by Identity Ipswich Web Design